Vigilare Wealth Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-10,200
Closed -$296K 204
2021
Q3
$296K Buy
+10,200
New +$339K 0.18% 148
2021
Q1
Sell
-4,675
Closed -$221K 214
2020
Q4
$221K Sell
4,675
-295
-6% -$13.7K 0.21% 121
2020
Q3
$232K Sell
4,970
-1,090
-18% -$37.4K 0.24% 102
2020
Q2
$219K Buy
+6,060
New +$223K 0.22% 101

Other funds holding ZYME

Vigilare Wealth Management's ZYME Position: Q4 2021 in Review

Vigilare Wealth Management sold out of Zymeworks (ZYME) in Q4 2021, closing a stake of 10,200 shares — an estimated $296K sold.

Vigilare Wealth Management first reported a position in ZYME in Q2 2020 and held it in 4 quarters. The position peaked at $296K in Q3 2021. 114 funds tracked by Wall St. Rank hold ZYME as of Q4 2021.

  • Vigilare Wealth Management reported no remaining Zymeworks position as of Q4 2021 after selling out during the quarter.
  • Vigilare Wealth Management sold 10,200 Zymeworks shares in Q4 2021, an estimated $296K.
  • Vigilare Wealth Management first reported a position in Zymeworks in Q2 2020 and held it in 4 quarters.
  • Vigilare Wealth Management's Zymeworks position peaked at $296K in Q3 2021.
  • 114 funds tracked by Wall St. Rank held Zymeworks as of Q4 2021.

Based on Vigilare Wealth Management's 13F filing for Q4 2021, filed 7 Jan 2022.